(1->4)-beta-D-glucan multiple interactions ISO RGD:1619000 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FLVCR2 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:1619000 6480464 vinylidene chloride results in decreased expression of FLVCR2 mRNA CTD PMID:26682919 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FLVCR2 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1352163 6480464 Estradiol results in increased expression of FLVCR2 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:1352163 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of FLVCR2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FLVCR2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FLVCR2 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1619000 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FLVCR2 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1619000 6480464 Tetrachlorodibenzodioxin results in decreased expression of FLVCR2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1619000 6480464 Tetrachlorodibenzodioxin affects the expression of FLVCR2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352163 6480464 Tetrachlorodibenzodioxin results in increased expression of FLVCR2 mRNA CTD PMID:22903824 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-sulfonyldiphenol increases expression ISO RGD:1352163 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FLVCR2 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol increases expression ISO RGD:1619000 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FLVCR2 mRNA CTD PMID:30951980 acetamide increases expression EXP 6480464 acetamide results in increased expression of FLVCR2 mRNA CTD PMID:31881176 all-trans-retinoic acid decreases expression ISO RGD:1352163 6480464 Tretinoin results in decreased expression of FLVCR2 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1352163 6480464 Antirheumatic Agents results in decreased expression of FLVCR2 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1619000 6480464 Benzo(a)pyrene results in decreased expression of FLVCR2 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1352163 6480464 Benzo(a)pyrene affects the methylation of FLVCR2 exon, Benzo(a)pyrene affects the methylation of FLVCR2 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1352163 6480464 Benzo(a)pyrene results in decreased methylation of FLVCR2 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1619000 6480464 Benzo(a)pyrene results in increased expression of FLVCR2 mRNA CTD PMID:27195522 benzo[b]fluoranthene decreases expression ISO RGD:1619000 6480464 benzo(b)fluoranthene results in decreased expression of FLVCR2 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:1352163 6480464 benzo(e)pyrene results in increased methylation of FLVCR2 intron CTD PMID:30157460 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of FLVCR2 mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FLVCR2 mRNA CTD PMID:32145629 bisphenol A increases expression ISO RGD:1619000 6480464 bisphenol A results in increased expression of FLVCR2 mRNA CTD PMID:25594700 , PMID:34585602 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FLVCR2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases expression ISO RGD:1619000 6480464 bisphenol A results in decreased expression of FLVCR2 mRNA CTD PMID:26063408 bisphenol F increases expression ISO RGD:1619000 6480464 bisphenol F results in increased expression of FLVCR2 mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FLVCR2 mRNA CTD PMID:32479839 cadmium dichloride increases expression ISO RGD:1352163 6480464 Cadmium Chloride results in increased expression of FLVCR2 mRNA CTD PMID:25596134 carbon nanotube increases expression ISO RGD:1619000 6480464 Nanotubes, Carbon analog results in increased expression of FLVCR2 mRNA CTD PMID:25620056 chloroacetaldehyde increases expression ISO RGD:1352163 6480464 chloroacetaldehyde results in increased expression of FLVCR2 mRNA CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:1619000 6480464 Chlorpyrifos results in increased expression of FLVCR2 mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:1619000 6480464 chromium hexavalent ion affects the expression of FLVCR2 mRNA CTD PMID:28472532 cidofovir anhydrous affects expression ISO RGD:1352163 6480464 Cidofovir affects the expression of FLVCR2 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1352163 6480464 Cisplatin results in decreased expression of FLVCR2 mRNA CTD PMID:25596134 clobetasol decreases expression ISO RGD:1619000 6480464 Clobetasol results in decreased expression of FLVCR2 mRNA CTD PMID:27462272 clodronic acid increases expression ISO RGD:1352163 6480464 Clodronic Acid results in increased expression of FLVCR2 mRNA CTD PMID:25596134 copper atom multiple interactions ISO RGD:1352163 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FLVCR2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1352163 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FLVCR2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1352163 6480464 Copper Sulfate results in increased expression of FLVCR2 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1352163 6480464 Cyclosporine results in decreased expression of FLVCR2 mRNA CTD PMID:20106945 , PMID:25596134 dibutyl phthalate decreases expression ISO RGD:1619000 6480464 Dibutyl Phthalate results in decreased expression of FLVCR2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FLVCR2 mRNA CTD PMID:21266533 dioxygen affects expression ISO RGD:1352163 6480464 Oxygen deficiency affects the expression of FLVCR2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1352163 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLVCR2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352163 6480464 Doxorubicin results in decreased expression of FLVCR2 mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of FLVCR2 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:1619000 6480464 epoxiconazole results in increased expression of FLVCR2 mRNA CTD PMID:35436446 folic acid decreases expression ISO RGD:1619000 6480464 Folic Acid results in decreased expression of FLVCR2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1352163 6480464 Formaldehyde results in increased expression of FLVCR2 mRNA CTD PMID:28937961 furan increases expression EXP 6480464 furan results in increased expression of FLVCR2 mRNA CTD PMID:25539665 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FLVCR2 mRNA CTD PMID:33387578 ifosfamide decreases expression ISO RGD:1352163 6480464 Ifosfamide results in decreased expression of FLVCR2 mRNA CTD PMID:25596134 inulin multiple interactions ISO RGD:1619000 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FLVCR2 mRNA CTD PMID:36331819 lipopolysaccharide increases expression ISO RGD:1352163 6480464 Lipopolysaccharides results in increased expression of FLVCR2 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1352163 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FLVCR2 mRNA CTD PMID:35811015 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of FLVCR2 mRNA CTD PMID:28801915 metformin increases expression EXP 6480464 Metformin results in increased expression of FLVCR2 mRNA CTD PMID:25596134 , PMID:31324951 methapyrilene increases methylation ISO RGD:1352163 6480464 Methapyrilene results in increased methylation of FLVCR2 intron CTD PMID:30157460 nickel atom increases expression ISO RGD:1352163 6480464 Nickel results in increased expression of FLVCR2 mRNA CTD PMID:25583101 ozone multiple interactions ISO RGD:1619000 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FLVCR2 mRNA CTD PMID:34911549 paracetamol decreases expression ISO RGD:1352163 6480464 Acetaminophen results in decreased expression of FLVCR2 mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FLVCR2 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1352163 6480464 perfluorooctane sulfonic acid results in increased expression of FLVCR2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1619000 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FLVCR2 mRNA more ... CTD PMID:36331819 pirinixic acid increases expression ISO RGD:1619000 6480464 pirinixic acid results in increased expression of FLVCR2 mRNA CTD PMID:17426115 , PMID:23811191 protein kinase inhibitor multiple interactions ISO RGD:1352163 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FLVCR2 mRNA] CTD PMID:28003376 quercetin decreases expression ISO RGD:1352163 6480464 Quercetin results in decreased expression of FLVCR2 mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of FLVCR2 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352163 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FLVCR2 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1352163 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLVCR2 mRNA CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1352163 6480464 sodium arsenite results in decreased expression of FLVCR2 mRNA CTD PMID:34032870 sodium dichromate decreases expression ISO RGD:1352163 6480464 sodium bichromate results in decreased expression of FLVCR2 mRNA CTD PMID:17685462 sulforaphane decreases expression ISO RGD:1352163 6480464 sulforaphane results in decreased expression of FLVCR2 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1352163 6480464 Sunitinib results in increased expression of FLVCR2 mRNA CTD PMID:31533062 tetrachloroethene increases expression ISO RGD:1619000 6480464 Tetrachloroethylene results in increased expression of FLVCR2 mRNA CTD PMID:28973375 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FLVCR2 mRNA CTD PMID:23411599 , PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FLVCR2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1352163 6480464 trichostatin A results in increased expression of FLVCR2 mRNA CTD PMID:24935251 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of FLVCR2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1619000 6480464 triptonide results in increased expression of FLVCR2 mRNA CTD PMID:33045310 valproic acid increases expression ISO RGD:1352163 6480464 Valproic Acid results in increased expression of FLVCR2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1352163 6480464 Valproic Acid affects the expression of FLVCR2 mRNA CTD PMID:25979313 vorinostat multiple interactions ISO RGD:1352163 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLVCR2 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1352163 6480464 vorinostat results in increased expression of FLVCR2 mRNA CTD PMID:26272509